theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Obstetrics & Gynecology

Dermatology   

Questions discussed in this category


In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?
Does the answer differ if mother remained on TNFi throughout pregnancy?
1 Answer available
25374

Related Topics in Obstetrics & Gynecology

  • Primary Care
  • Hematology
  • Benign Hematology
  • Pregnancy
  • Medical Oncology
  • Women's Mental Health
  • General Outpatient Psychiatry
  • Psychiatry
  • Rheumatology
  • Endocrinology

Copyright © 2025 theMednet
All Rights Reserved.